Allogeneic CD30 Chimeric Antigen Receptor Epstein-Barr Virus-Specific T Lymphocytes in Relapsed or Refractory CD30-Positive Lymphomas
Baylor College of Medicine
Baylor College of Medicine
Sorrento Therapeutics, Inc.
National Institutes of Health Clinical Center (CC)
Rutgers, The State University of New Jersey
National Cancer Centre, Singapore
University of California, San Diego
University of Texas Southwestern Medical Center
University of Miami
Rutgers, The State University of New Jersey
Rutgers, The State University of New Jersey
Fred Hutchinson Cancer Center
Children's Oncology Group
Barbara Ann Karmanos Cancer Institute
Vanderbilt-Ingram Cancer Center
M.D. Anderson Cancer Center
Enzon Pharmaceuticals, Inc.